vimarsana.com

Latest Breaking News On - International laboratories - Page 11 : vimarsana.com

Proteomics International Laboratories Ltd (ASX:PIQ) International Webinar and Q&A

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to invite shareholders, investors and interested parties to an online update on the recent announcement regarding the PromarkerD US Reimbursement Price.

Western australiaRichard lipscombeProteomics international laboratories ltdProteomics international laboratoriesProteomics internationalProteomics international webinarInternational webinarInternational laboratories ltdAustralian regulatory decisionInternational laboratoriesHealth pharm generalproteomics international laboratories ltdAsx piq

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD US Reimbursement Price & Aus Regulatory Decision

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce a major milestone in the commercialisation of its predictive test for diabetic kidney disease, PromarkerD, with the US Centers for Medicare & Medicaid Services.

Western australiaUnited statesRichard lipscombeAustralian therapeutic goods administrationAmerican medical associationUs centers for medicare medicaid servicesMedicare advisory panel on clinical diagnostic laboratoryProteomic internationalCptr proprietary laboratory analysesProteomics internationalProteomics international laboratories ltdJanssen research developmentCenters for medicare medicaid servicesLaboratory developed testTherapeutic goods administration australiaProteomics international laboratories

Proteomics International Laboratories Limited s (ASX:PIQ) Shift From Loss To Profit

Proteomics International Laboratories Limited ( ASX:PIQ ) is possibly approaching a major achievement in its business.

Management teamProteomics international laboratoriesProteomics international laboratorieInternational laboratoriesSimply wallHigh performing stocks

Proteomics International Laboratories Ltd (ASX:PIQ) New Oesophageal Cancer Test Presented at Global Conference

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce its latest results for its novel blood test for oesophageal adenocarcinoma will be presented tomorrow at the 19th ISDE World Congress for Esophageal Diseases.

United statesWestern australiaRichard lipscombeProteomics internationalProgression of barrett esophagus to cancer networkLaboratory developed testProteomics international laboratories ltdSummary of the diagnostic test developmentUs laboratory developed testEconomic health benefitOchsner health systemInternational society for diseases of the esophagusWorld congressProteomics international laboratoriesEsophageal diseasesOesophageal cancer test presented

Proteomics International Laboratories Ltd (ASX:PIQ) OxiDx Platform Technology Secures Patent in Japan

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce that its subsidiary OxiDx Pty Ltd has been granted a patent in Japan for its platform technology to measure oxidative stress.

Western australiaRichard lipscombeIan brownProteomics international laboratoriesProteomics internationalUniversity of western australiaOxidx pty ltdProteomics international laboratories ltdHorse racing industriesInternational laboratories ltdProfessional sportsHorse racingDuchenne muscularInternational laboratoriesClinical trialsHealth pharm generalproteomics international laboratories ltd

vimarsana © 2020. All Rights Reserved.